(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

OJEMDA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

OJEMDA

ST13

US500000098030463

Class

5, 42, 44

Filing

98030463

Registration

7871167

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

31

Latest update

07/17/2026

Classification

Registered

Trademark type

Word

Nice classes

5, 42, 44

Filing date

06/06/2023

Registration date

07/22/2025

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/22/2025

Last transaction

07/17/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

05/06/2024

First use in commerce

05/06/2024

Drawing code

4

Owner type

03

Owner location

Brisbane, CA, US

Examiner

I, DAVID C

Law office

M50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Day One Biopharmaceuticals, Inc.

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparations for human use for the treatment of cancer; pharmaceutical preparation for the prevention and treatment of cancer; pharmaceutical preparations for the treatment of oncological diseases; pharmaceutical preparations and substances for the prevention and treatment of oncological diseases and disorders; targeted pharmaceutical preparations for use in the field of cancer prevention and treatment; pharmaceutical preparations for the delivery of compounds to the body for the treatment and prevention of oncological related diseases and disorders

Class 42

Researchdevelopmentproduct evaluation of pharmaceutical preparations for the prevention and treatment of cancer; laboratory analysis and research of drugs and pharmaceutical products; research and development services in the fields of oncologyimmunotherapychemotherapycombination therapies for the treatment of cancer and tumors; providing medical research information in the fields of oncologyimmunotherapychemotherapy and combination therapies; scientific advisory servicesproviding scientific informationadviceconsultancy in the field of cancer treatment; designdevelopmentresearchtesting of new productsdrugs and pharmaceuticals for the treatment and/or prevention of oncological diseases and disorders

Class 44

Medical information services; healthcare servicesproviding cancer treatment information to physicianshealth care professionalspatients; medical information servicesproviding information regarding oncological diseases and disorders

Publications

History of USPTO decisions and trademark events.

31 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/16/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/16/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/16/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/16/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/16/2026

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/22/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

07/22/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

07/16/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

06/27/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

05/22/2025

SUPC

STATEMENT OF USE PROCESSING COMPLETE

05/21/2025

EISU

TEAS STATEMENT OF USE RECEIVED

02/28/2025

IUAF

USE AMENDMENT FILED

02/27/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/10/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

01/10/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

01/10/2025

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/03/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/09/2024

PUBO

PUBLISHED FOR OPPOSITION

07/09/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

06/19/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/31/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

05/31/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

05/31/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

05/31/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

05/31/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

03/04/2024

GNRT

NON-FINAL ACTION E-MAILED

03/04/2024

CNRT

NON-FINAL ACTION WRITTEN

03/04/2024

DOCK

ASSIGNED TO EXAMINER

02/27/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/11/2023

NWAP

NEW APPLICATION ENTERED

06/09/2023

Continuous trademark protection

Get notified about every new filing that threatens OJEMDA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.